Snapshot from Aug 19, 2026 at 07:00 UTC. For live data and tracking: View Live
Business class action lawsuit

Insulet Class Action Lawsuit Filed

Analysis based on 19 articles · First reported Jul 02, 2026 · Last updated Jul 13, 2026

Sentiment
-60
Attention
4
Articles
19
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The class action lawsuit against Oracle Corporation and its product recalls have negatively impacted the company's stock price, causing significant drops. This event creates uncertainty for investors in the medical device industry, particularly those holding shares of Oracle Corporation.

Medical Devices Pharmaceuticals

Robbins LLP has filed a class action lawsuit against Oracle Corporation on behalf of investors who purchased securities between February 21, 2025, and May 26, 2026. The lawsuit alleges that Oracle Corporation misled investors by failing to disclose defective manufacturing controls and procedures, which led to two voluntary Medical Device Corrections for its Omnipod products in March and May 2026. These corrections, due to manufacturing issues that could result in insulin under-delivery, caused Oracle Corporation's stock price to fall significantly on both occasions.

100 Robbins LLP filed class action lawsuit Oracle Corporation
90 Oracle Corporation initiated Medical Device Correction
stock
Oracle Corporation is facing a class action lawsuit for allegedly misleading investors about defective manufacturing controls and procedures, which led to product recalls and a significant drop in its stock price.
Importance 100.0 Sentiment -70.0
priv
Robbins LLP is a shareholder rights law firm that filed the class action lawsuit against Oracle Corporation on behalf of investors.
Importance 70.0 Sentiment 50.0
per
Aaron Dumas, Jr. is an attorney at Robbins LLP involved in the class action lawsuit against Oracle Corporation.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.